Diabetes, sugar-coated but harmful to the brain

Current Opinion in Pharmacology

Volumn 7, Issue 6, 2007, Pages 638-642

  Starr, Vanessa L ^a   Convit, Antonio ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; ESTROGEN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; TAU PROTEIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BLOOD VESSEL REACTIVITY; BRAIN DISEASE; BRAIN PROTECTION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIC; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LEARNING DISORDER; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; RISK FACTOR;

ANIMALS; BRAIN; DEMENTIA; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE;

EID: 36549011670     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.10.007     Document Type: Review

References (47)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329 (1993) 977-986
2. Vinereanu D. Risk factors for atherosclerotic disease: present and future. Herz 31 Suppl 3 (2006) 5-24
3. Wessels A., Rombouts S., Remijnse P., Boom Y., Scheltens P., Barkhof F., Heine R., and Snoek F. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 50 (2007) 1763-1769
4. Brands A.M.A., Biessels G.J., de Haan E.H.F., Kappelle L.J., and Kessels R.P.C. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 (2005) 726-735
5. Brands A.M., Biessels G.J., Kappelle L.J., de Haan E.H., de Valk H.W., Algra A., and Kessels R.P. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 23 (2007) 343-350
6. Lobnig B.M., Kroemeke O., Optenhostert-Porst C., and Wolf O.T. Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabetic Med 23 (2006) 32-39
7. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T: Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007, doi:10.2337/dc07-0351.
8. Eppens M.C., Craig M.E., Cusumano J., Hing S., Chan A.K.F., Howard N.J., Silink M., and Donaghue K.C. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29 (2006) 1300-1306
9. Biessels G.-J., ter Braak E., Erkelens D., and Hijman R. Cognitive function in patients with type 2 diabetes mellitus. Neurosci Res Commun 28 (2001) 11-22
10. Akisaki T., Sakurai T., Takata T., Umegaki H., Araki A., Mizuno S., Tanaka S., Ohashi Y., Iguchi A., Yokono K., and Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 22 (2006) 376-384
11. Strachan M., Deary I., Ewing F., and Frier B. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20 (1997) 438-445
12. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan K.M., and Cummings S.R. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160 (2000) 174-180
13. Manschot S.M., Brands A.M.A., van der Grond J., Kessels R.P.C., Algra A., Kappelle L.J., Biessels G.J., and on behalf of the Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55 (2006) 1106-1113
14. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., and Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50 4 (2007) 711-719
15. den Heijer T., Vermeer S.E., van Dijk E.J., Prins N.D., Koudstaal P.J., Hofman A., and Breteler M.M. Type 2 diabetes and atrophy of the medial temporal lobe structures. Diabetologia 46 (2003) 1604-1610
16. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., and Palumbo P.J. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145 (1997) 301-308
17. Baldereschi M., Di Carlo A., Lepore V., Bracco L., Maggi S., Grigoletto F., Scarlato G., and Amaducci L. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50 (1998) 996-1002
18. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., and Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45 (1995) 51-55
19. Grodstein F., Chen J., Pollen D.A., Albert M.S., Wilson R.S., Folstein M.F., Evans D.A., and Stampfer M.J. Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 48 (2000) 746-752
20. Henderson A.S., Jorm A.F., Christensen H., Jacomb P.A., and Korten A.E. Aspirin, anti-inflammatory drugs and risk of dementia. Int J Geriatr Psychiatry 12 (1997) 926-930
21. Li Z.G., Zhang W., and Sima A.A.F. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56 (2007) 1817-1824
22. Biessels G.J., Staekenborg S., Brunner E., Brayne C., and Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5 (2006) 64-74
23. Arvanitakis Z., Schneider J.A., Wilson R.S., Li Y., Arnold S.E., Wang Z., and Bennett D.A. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67 (2006) 1960-1965
24. Peila R., Rodriguez B.L., and Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51 (2002) 1256-1262
25. Heitner J., and Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49 (1997) 1306-1311
26. Beeri M.S., Silverman J.M., Davis K.L., Marin D., Grossman H.Z., Schmeidler J., Purohit D.P., Perl D.P., Davidson M., Mohs, et al. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol Seri A Biol Sci Med Sci 60 (2005) 471-475
27. Kivipelto M., Soininen H., and Tuomilehto J. Hypertension and white matter lesions of the brain. J Hypertension 20 (2002) 387-389
28. Taki Y., Goto R., Evans A., Zijdenbos A., Neelin P., Lerch J., Sato K., Ono S., Kinomura S., Nakagawa, et al. Voxel-based morphometry of human brain with age and cerebrovascular risk factors. Neurobiol Aging 25 (2004) 455-463
29. Goldstein I.B., Bartzokis G., Guthrie D., and Shapiro D. Ambulatory blood pressure and the brain: a 5-year follow-up. Neurology 64 (2005) 1846-1852
30. Waldstein S.R., Manuck S.B., Ryan C.M., and Muldoon M.F. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull 110 (1991) 451-468
31. Gold S.M., Dziobek I., Rogers K., Bayoumy A., McHugh P.F., and Convit A. Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity. J Clin Endocrinol Metab 90 (2005) 3262-3267
32. Raz N., Rodrigue K.M., and Acker J.D. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci 117 (2003) 1169-1180
33. van Exel E., de Craen A.J., Gussekloo J., Houx P., Bootsma-van der Wiel A., Macfarlane P.W., Blauw G.J., and Westendorp R.G. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 51 (2002) 716-721
34. Henderson V.W., Guthrie J.R., and Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 74 (2003) 1530-1535
35. Hajjar I., Schumpert J., Hirth V., Wieland D., and Eleazer G.P. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol A Biol Sci Med Sci 57 (2002) M414-M418
36. Reitz C., Luchsinger J., Tang M.-X., Manly J., and Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 64 (2005) 1378-1383
37. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G., and on behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 100 (1997) 1166-1173
38. Smith D.O., and LeRoith D. Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus. Clin Cornerstone 6 (2004) 7-13
39. Vanhanen M., Koivisto K., Karjalainen L., Helkala E.L., Laakso M., Soininen H., and Riekkinen Sr. P. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. Neuroreport 8 (1997) 1527-1530
40. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
41. Kalmijn S., Feskens E.J.M., Launer L.J., Stijnen T., and Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 38 (1995) 1096-1102
42. Convit A., Wolf O.T., Tarshish C., and de Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 100 (2003) 2019-2022
43. Pavkov M.E., Bennett P.H., Knowler W.C., Krakoff J., Sievers M.L., and Nelson R.G. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296 (2006) 421-426
44. Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 26 (2005) 31-35
45. Ahmad F., Considine R.V., Bauer T.L., Ohannesian J.P., Marco C.C., and Goldstein B.J. Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 46 (1997) 1140-1145
46. Pontiroli A.E., Folli F., Paganelli M., Micheletto G., Pizzocri P., Vedani P., Luisi F., Perego L., Morabito A., Bressani Doldi, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 28 (2005) 2703-2709
47. Meneilly G.S., Cheung E., Tessier D., Yakura C., and Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48 (1993) M117-M121